Annual sales of Exparel are estimated at 39 million in the US. Pacira is planning to develop partnerships to market Exparel outside the US. Image courtesy of Pacira Pharmaceuticals.
-
Exparel is a combination of bupivacaine with DepoFoam. -
DepoFoam is a product delivery mechanism. -
Annual sales of Exparel are estimated at 39 million units in the US.
Twitter
Facebook